Gómez-Peralta, Fernando http://orcid.org/0000-0003-0106-0091
Leiva-Gea, Isabel http://orcid.org/0000-0002-2259-7253
Duque, Natalia http://orcid.org/0000-0002-9587-0679
Artime, Esther http://orcid.org/0000-0003-4294-6462
Rubio de Santos, Miriam http://orcid.org/0000-0001-7393-6334
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 15 March 2024
Accepted: 3 July 2024
First Online: 2 August 2024
Declarations
:
: Fernando Gómez-Peralta reports research funds for ISS study from Abbott Diabetes and speaker honoraria from Abbott Diabetes and Eli Lilly and Company. Isabel Leiva-Gea has received support from Medtronic Diabetes for educational events and reports speaker honoraria from Eli Lilly and Company. Natalia Duque, Esther Artime, and Miriam Rubio de Santos are employees and minor shareholders of Eli Lilly and Company.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.